Weight Loss & Obesity News, Features & Updates

Zepbound is a dual GIP and GLP-1 receptor agonist that can help with weight loss as part of a treatment plan with diet and exercise changes. An expert shares what you should know.

Foundayo is a new weight loss pill. Here’s a closer look at how it works, what to expect, side effects, and how it compares to injectables.

April 1, 2026 — The FDA has approved Foundayo (orforglipron) as a once‑daily GLP-1 pill to help adults lose excess weight and keep it off long term.

April 1, 2026 — Thirty years after its discovery, scientists are eyeing leptin with renewed interest, for everything from weight loss drug cocktails to novel treatments for rare diseases and anorexia.

March 20, 2026 — Imcivree (setmelanotide), a shot that treats a rare type of obesity linked to Bardet-Biedl syndrome and certain genetic conditions, has been approved treat acquired hypothalamic obesity (HO) in adults and children ages 4 years and older.

February 6, 2026 — Next-gen weight loss medications are powerful – but eating too little can put some patients at serious nutritional risk.

December 30, 2025 — The Wegovy pill has hit the market, joining injectable GLP-1 drugs that have transformed obesity treatment. One form you swallow, the other you inject. What else is different?

December 4, 2025 — Microdosing GLP-1 weight loss medications – using very small amounts of the popular and pricey drugs – seems to be everywhere, but a lack of clinical trial data on the practice has some experts concerned about safety.

Destiny Murtaugh is rewriting the story of weight and reclaiming the term “fat” one post at a time.

If you are overweight or have obesity, a healthy body image is important. Here’s how body image affects weight loss, plus ways to get a more positive body image.

Learn about the link between mental health and obesity, and what you might do about it.

In the quest for better health, it helps to find your balance first and to start with goals you can achieve while considering the full picture.

Dance is for everyone. Find out how dance can improve both physical and mental health and how to get started.

Body mass index uses your height and weight to estimate your body fat. Here’s what this number can and can’t tell you about your health.

Self-advocacy can help to ensure you get all you need from your doctor, and it’s especially essential when you’re living with obesity. Learn ways to advocate for yourself with doctors from people who really understand.

Jessie Diaz-Herrera hasn’t allowed weight bias to stop her moves. Learn how she’s “freeing the jiggle” and embracing joy.

What is atypical anorexia, and how does it affect people who don’t fit the stereotype of living with an eating disorder?

Latoya Snell breaks barriers in running as a “body-neutral” advocate for coloring outside the finish line.

A healthy diet is about more than your weight. It’s about fueling your body to run well throughout all of life’s circumstances.

Weight bias and stigma are common problems in obesity health care and may be having real consequences for your health. Learn how to spot bias and medical gaslighting and advice on how to overcome it.

Traumatic experiences can affect how people experience hunger and satiety, how well they metabolize food, and how well their pancreas is functioning. Stress hormones affect our tendency to hold on to calories and put on weight.

July 31, 2025 — As new research spotlights the obesity-cancer connection, experts warn we’ve underestimated just how much excess weight – and the complex biology behind it – can fuel the disease.

It’s well known that too much screen time may be bad for you. But there is also a strong connection between too much screen time and your metabolism. For adults and children, even small amounts of extra time spent in front of screens can cause weight gain and worsen your health.

July 29, 2025 — More and more doctors and scientists say BMI alone won’t tell you much about health, yet it remains the standard assessment for diagnosing obesity. Here’s why.

Weight loss drugs such as Ozempic are hugely popular, but that doesn’t mean they’re accessible. Cost, availability, and socioeconomic disparities mean that people who need them the most may not have access.

Unexpected body image issues and negative feelings may arise after significant weight loss.

July 17, 2025 — Modern weight loss medications represent a breakthrough, but they are most effective when combined with the right lifestyle strategies. Here's what that looks like.

A family doctor and obesity specialist talks about strange side effects that can result from weight loss and what you can do about them.

Now that the FDA shortage rules have expired, what’s next for people taking compound GLP-1s? Find out what you can do.

May 12, 2025 — In the first head-to-head trial of its kind, people with obesity who took tirzepatide (sold under the brand names Mounjaro and Zepbound) lost more weight and inches from their waist than those who took semaglutide (Ozempic, Wegovy).

April 14, 2025 — The FDA and the maker of the popular diabetes and weight loss drug Ozempic are warning people not to use counterfeit semaglutide 1.0 milligrams — the Ozempic injection — found in the U.S. drug supply chain.

March 26, 2025 — A new study suggests that restoring the pleasure of eating – not suppressing it – may help people eat more intentionally and avoid falling into patterns, offering a possible new way to treat obesity.

March 13, 2025 — A new study says that married men may have triple the risk of obesity, compared to unmarried men, and that marriage seems to increase the likelihood of being overweight in both sexes – by 62% in men and 39% in women.

Medical students spend, on average, just 10 hours on obesity education, according to recent research.

February 12, 2025 — People with type 2 diabetes taking GLP-1 medicines may experience potentially blinding eye conditions as soon as the day after starting the drugs, and eye doctors are now asking their patients to be vigilant in speaking up about any vision changes while taking them.

February 7, 2025 — People living in areas where obesity is more common may experience less stigma, which could help reduce some of the social and health consequences of being overweight.

January 17, 2025 — Medicare will negotiate the prices of weight loss drugs Wegovy and Ozempic with drug companies, a move that could create big savings for seniors who take the drugs, the Biden administration announced Friday.

December 5, 2024 — Ozempic and other GLP-1 drugs have surged in popularity, dominating U.S. medication spending in 2023 for their effectiveness in managing diabetes and promoting weight loss. As demand grows, promising new drugs like tirzepatide and retatrutide—offering even greater weight-loss potential—could become the “next Ozempic,” though high costs, side effects, and limited access remain significant challenges.

December 4, 2024 — People taking the weight loss drug Zepbound experienced dramatically greater weight loss than competitor Wegovy in the first head-to-head trial.

December 2, 2024 — Taking weight loss drugs like Wegovy and Zepbound can help people cut back on what they eat and also on what they drink – including alcohol.

November 26, 2024 — In its announcement, the Biden administration called anti-obesity medicines “life-saving drugs,” noting that they can also prevent diabetes.

November 19, 2024 — More than half of U.S. adults now qualify to take semaglutide, the popular diabetes and weight loss drug sold under the brand names Ozempic and Wegovy.

November 19, 2024 — The critical key to weight loss success? Sustainability. No single diet or plan works for everybody, but a secret formula does exist – and it’s unique to you.

November 12, 2024 — As the FDA issues a new warning about aspiration across all GLP-1 weight loss drugs, doctor groups are giving new recommendations.

November 6, 2024 — Labels for drugs like Mounjaro, Ozempic, and Saxenda now warn against aspiration risk during surgery.

See quick ways to make planks, squats, bridges, push-ups, jumping jacks, and ab exercises easier to do if you have obesity.

October 31, 2024 — A new study suggests that weekly self-injections of the weight loss drug semaglutide could reduce knee pain from moderate osteoarthritis by nearly 50%.

Compounding pharmacies can make versions of semaglutide (Wegovy) and tirzepatide (Zepbound). Here’s what to look out for.

September 24, 2024 — A new CDC report says severe obesity is becoming more common in the U.S. Nearly 1 in 10 adults have severe obesity, and women are more likely than men to have the health condition. Yet from 2013 to 2023, the overall obesity rate held relatively steady around 40%.